Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of ODZ2 mRNA | decreases expression | 20406850
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ODZ2 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of ODZ2 mRNA | increases expression | 20458559
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ODZ2 mRNA | affects cotreatment|decreases expression | 18164116
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ODZ2 mRNA | decreases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of ODZ2 mRNA | increases expression | 18007998
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ODZ2 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ODZ2 mRNA | affects cotreatment|decreases expression | 18164116
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ODZ2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of ODZ2 mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ODZ2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.68 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.07 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.46 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.46 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.66 | 6695378 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.66 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.66 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
10.75 | 17162532 19061943 16434500 19052882 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.75 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.45 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.23 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
9.23 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.25 | 19183758 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18177632 20603192 19232924 18316065 18396377 18985861 19460635 17507914 18940202 18558336 18775368 15238991 17688650 17157402 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.14 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.47 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.47 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.49 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.00 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.90 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.90 | 17474063 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.48 | 11589617 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.71 | 15073043 16217749 15553829 14691202 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.71 | 20101231 16540662 16878318 17978847 18494052 18665156 18210153 18691550 18978308 17428255 18788625 16681979 16328049 16830150 19052882 20935162 3084413 18056438 19919837 19171122 20512989 17173139 20214788 11831363 19383236 19418558 20727157 16779866 16935385 20524982 17162532 16698587 16569478 19519916 17761372 20007298 19107877 19539802 10672840 21159647 17055752 20432363 18506893 17138121 19701751 20084675 18393292 19335982 16502159 19394651 20514400 3581430 19208518 18971187 16288022 18785209 16807293 10737359 19822196 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.18 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.09 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.25 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.08 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.71 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.71 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.71 | 17174075 7505956 21159647 2727394 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.75 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.81 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.10 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.10 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.35 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.74 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.74 | 16575769 17688650 8888407 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.50 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.19 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.22 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.48 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.48 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.48 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.20 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.62 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.33 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.13 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.00 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.71 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.47 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.26 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.33 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.54 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.54 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
26.24 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
26.24 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
26.24 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
26.24 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
26.24 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.10 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.29 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.32 | 12168785 12639820 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.42 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.13 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.52 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.72 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.62 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.17 | 18467677 19176532 16221962 19772884 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.06 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.14 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.13 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.44 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.61 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.61 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.41 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.67 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.89 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.93 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.50 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.53 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.90 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.98 | 16968895 19850784 16467208 20471514 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.98 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.30 | 12712474 11161223 19075265 17869043 19642359 19225113 16112521 16330433 19035177 15748426 11468182 12018890 16891316 16966277 15213294 17649720 17712046 15336539 17217047 16331271 9834237 15622746 17107899 12679006 16823087 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.51 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.93 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.89 | 18665156 20032147 18522880 19638242 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.13 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
18.63 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
18.63 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
18.63 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
18.63 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
18.63 | 18754104 19073162 19426721 9163691 19638242 19690152 20452335 20501860 18977376 19833225 15885732 19996281 15175105 19255062 20434301 19551842 18648771 19256749 19254457 20118626 19850985 20583210 18644402 2422723 20101389 12771043 19812893 2862719 19499222 19427195 21167192 20405173 19294768 20137499 21278145 18978307 20492335 10737359 19642983 21071580 12112319 21047994 19090486 16942905 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
18.63 | 20007298 16377806 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.87 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.87 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
14.87 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.87 | 19004024 18079962 2563599 18308698 18282651 17854601 18093689 19539802 18164116 21159647 9362446 16842330 17174075 18544905 17942915 18775883 18253720 19009564 19126423 16267830 3124819 19519916 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.46 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.48 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.51 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.51 | 18569708 20464547 20869020 18520028 6695378 18816296 17053015 20064080 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
3.51 | 20970405 20512841 6695378 21163286 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.29 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.30 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.20 | 19549372 11468182 15949261 14977855 19417148 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.17 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.89 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.67 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.67 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.05 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.12 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.61 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.03 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.03 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.13 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.62 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.62 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.46 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.33 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.56 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.18 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.44 | 19769630 16624393 12452020 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.42 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.42 | 16540662 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.31 | 19927285 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
9.36 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
9.36 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
17.52 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
17.52 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
17.52 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.13 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.35 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.54 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.54 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.54 | 16740699 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.13 | 18629315 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.76 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.98 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.32 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.12 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.25 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.25 | 14763951 16876388 1511512 17978042 11044598 11738929 3137016 15475178 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.43 | 19755658 10029692 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.76 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.40 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.40 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.40 | 18456281 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.18 | 16684133 16045194 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.55 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.55 | 7505956 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.45 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.71 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.58 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.58 | 11780464 20435036 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.58 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.82 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.51 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.23 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |